Meridian Bioscience reported $997.58M in Market Capitalization for its second fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Abbott ABT:US $ 19.27B 3.08B
Accelerate Diagnostics AXDX:US $ 837.9M 379.81M
Antares Pharma ATRS:US $ 455.29M 64.57M
Becton, Dickinson and BDX:US $ 6.94B 691.08M
Bio Rad Laboratories BIO:US $ 1.33B 281.72M
Cerulean Pharma CERU:US $ 26.34M 5.36M
Cerus CERS:US $ 108.23M 32.82M
Genmark Diagnostics GNMK:US $ 102.49M 77.45M
Luminex LMNX:US $ 1.48B 227.66M
Meridian Bioscience VIVO:US $ 997.58M 637.81M
Myriad Genetics MYGN:US $ 845.45M 221.36M
Neogen NEOG:US $ 4.15B 40.46M
Orasure Technologies OSUR:US $ 870.87M 42.5M
Oxford Immunotec Global OXFD:US 30.38M 3.37M
Quidel QDEL:US $ 939.69M 528.93M
Rockwell Medical RMTI:US $ 136.81M 4.74M
Sientra SIEN:US $ 193.63M 94.16M
Staar Surgical STAA:US $ 2.59B 210.16M
Thermo Fisher Scientific TMO:US $ 17.47B 3.13B